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ABST RACT
Anorexia nervosa (AN) is a psychiatric disorder that predominantly affects
young women and is characterized by low caloric intake and a major
dissatisfaction with one’s body image. It is often overlooked and, while
patients and family seek medical help, emaciation and nutritional
misbalances may become extreme and potentially life threatening. Among
the many somatic complications, an accumulation of early endocrine
adaptations occurs, leading to functional amenorrhea and impaired
reproduction as a result of dysfunction of the hypothalamic-pituitary-ovarian
axis. Even though these conditions are reversible, long-term consequences
may affect the fertility of women with AN and can lead to maternal and fetal
complications during pregnancy and birth. This review presents the clinical
particularities of reproduction in the context of AN, along with the possible
pathophysiological mechanisms involved.

Introduction
Anorexia nervosa (AN) is an eating disorder that
consists of abnormally low body weight, a distorted
perception of body image, and a fear of gaining weight [1].
Patients suffering from this condition have a major
dissatisfaction with their body shape or size, and either
perceive themselves as being fat despite extreme
starvation, or become aware of their low weight but are in
denial of its seriousness. The patients have a negative
energy balance as a result of strict dieting or intense and
extreme physical exercise [2].
Semantically, anorexia nervosa means the “neurotic
loss of appetite,” the condition being described as long as
several centuries ago [3,4]. However, the diagnostic
criteria for AN have changed substantially over time, being
revised and redefined with each edition of the Diagnostic
and Statistical Manual of Mental Disorders (DSM).
Although in current medical practice, the DSM-IV criteria
are better known and applied, the most recent definition of
AN dates to 2013 when DSM-5 removed the condition for
amenorrhea from the diagnostic criteria, along with any
threshold value for defining “low weight” [3,5]. Despite
the fact that amenorrhea is common among patients
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suffering from AN, its assumption as a necessary element
in the diagnosis algorithm of AN was limiting, as it did not
take into consideration pre-pubertal or post-menopausal
females, or females under contraceptive treatment. As a
further matter, the DSM-IV definition was not inclusive of
male patients, as their gonadal axis status was not taken
into consideration [6,7].
Even though the actual diagnosis of AN is based solely
on clinical judgment, the DSM-5 task force recommended
using body mass index (BMI) for adults or corresponding
BMI percentiles for adolescents in order to classify disease
severity into four categories: mild (BMI>17kg/m2),
moderate (BMI 16-16.99kg/m2), severe (BMI 1515.99kg/m2), and extreme (BMI<15kg/m2). In addition,
the disease is given two subtypes: restrictive AN and
binge-eating/purging type, depending on patients’
behavior and their attitudes towards dieting, exercising, or
purging [5]. Last, the same task force defined atypical
anorexia nervosa as a distinct eating disorder that
encompasses all the features of typical AN, except low
weight.
As expected, the more lenient definition of AN has led
to an increase in its lifetime prevalence [8-10], which now
reaches 4% [11,12]. It can affect both sexes, but is much
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more common among females, with a male-to-female ratio
estimated to be 1:10. Even though it may occur at any age,
its highest incidence occurs before the age of 20 years
[5,13]. Its lifetime prognosis is good, although on a somatic
level, the complications from emaciation, poor nutrition, or
purging behavior may have long term effects. In addition,
from a psychiatric perspective, relapses are possible, as
well as association with other psychiatric diseases such as
depression, anxiety disorders, social phobia, or obsessivecompulsive disorder [14]. According to several studies,
approximately one fifth of all death causes of anorexic
patients lies in suicide, which, along with medical disorders
of the disease itself, raise the base mortality rate to 5% per
decade [15,16].
Little is known about the etiology and triggers of AN,
but genetic, environmental, and neurobiological factors
seem to be involved [17]. Among the many metabolic
complications, AN is characterized by an accumulation of
endocrine adaptations such as acquired growth hormone
(GH) resistance and subsequent low insulin-like growth
factor (IGF1), chronic adrenal stimulation, euthyroid sick
syndrome which, along with extreme starvation, is
responsible for a further decrease in energy expenditure
[3,18] and hypogonadotropic hypogonadism which leads
to low trabecular score, impaired bone mineral density
(BMD) [19], and functional amenorrhea. Considering that
affected women are less likely to start a family and have
children [20], this review addresses the issue of fertility and
reproduction of females with a lifetime diagnosis of AN.
The aim of this review is, first, to provide an in-depth
overview of the recent information regarding clinical and
biological anomalies of reproduction in AN female
subjects. A second objective is to define better clinical
approaches regarding menstrual disturbances and
pregnancy management in AN patients. Finally, we aim to
identify less-explored pathophysiological mechanisms and
potentially open new perspectives for further research in
the near future.
A comprehensive search of the current literature on
menstrual history, fertility and pregnancy, and birth
outcomes related to AN was conducted via PubMed
database in order to identify relevant studies published up
to December 2019. We also included terminology for some
of the biological and pathophysiological underpinnings of
these clinical outcomes. For this purpose, we used a series
of logical combinations of keywords and Medical Subject
Headings (MeSH) terms, as follows: “anorexia nervosa”,
“reproduction”, “fertility”, “pregnancy”, “kisspeptin”,
“leptin”, “gonadotrophs”, “neurotransmitters,” and
restriction to English language articles was made. No
restriction was made on date or study type, but priority was
given to recent clinical trials, although several relevant
reviews or animal studies were included. An initial search
identified 102 articles. We removed duplicates and
2

considered for critical review only full text articles relevant
to the topic, with 53 remaining articles included in our final
analyses. To these, information from 14 additional articles
or books was reviewed when documenting the
epidemiology and general traits of anorexia nervosa. The
present article is structured in two parts: in the first part we
deal with the clinical aspects of reproduction in AN, and in
the second part the mechanisms underlining them.

Discussions
Reproduction in the setting of AN
Optimal reproduction requires a mature and intact
hypothalamic-pituitary-ovarian-axis, which in conditions
of energy depletion and chronic stress can be difficult to
achieve. Clinical studies investigating the effects of
malnutrition and famine have shown that good
reproductive capacity depends on adequate nutritional
intake [21]. Furthermore, beyond the multiple somatic
dysfunctions of anorexia, the sparse emotional availability
of such patients leads to decreased libido and a rejection of
sexual activity [22], which may also alter the odds of
procreation. In this paper, we focus on clinical aspects that
govern the reproduction and fertility of anorexic females.
Menstrual disturbances in anorexic females
From an evolutionary perspective, reproduction and
growth are the first physiological processes to be sacrificed
under conditions of intense stress that threaten survival. If
anovulation is key to preservation, its clinical appearance
can embrace different forms, from delayed or arrested
puberty to menstrual irregularities or infertility, depending
on the time of onset of AN, its duration, and severity.
Consequently, females with AN can experience a wide
range of menstrual disorders, such as anovulatory
eumenorrhea, shortened or prolonged menses due to
defects of follicular or luteal phases, premenstrual spotting,
oligomenorrhea, or even amenorrhea [23].
Menarche is among the latter events in pubertal
development and it follows thelarche and the rise of
gonadal hormones by approximately 1.5-2 years. Evidence
suggests that a weight loss of merely 10 to 15% from the
normal weight-for-height can delay the age of menarche
and sexual development [22,24]. A study conducted on a
relatively large cohort of women (n=841) showed that 10%
of anorexic females experienced primary amenorrhea,
defined as a lack of menarche until the age of sixteen [24].
This same study emphasized the importance of age at onset
of disease, because the vast majority of patients with
primary amenorrhea experienced AN prior to the menarche
and also reached the personal weight nadir at a younger age
than patients with physiological menarche.
The same degree of weight loss of 10-15% from the
normal weight seems to lead to a cessation of menstrual
cycle in post-pubertal women as well [22,25]. So far, there
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are no clear predictive factors for the resumption of
menses. In 2013, Dempfle et al. showed that only half of
amenorrheic patients resumed menses within one year
from diagnosis, at a mean BMI of 19kg/m2 [26]. This
finding is consistent with previous data showing that by
one year from diagnosis, two thirds of anorexic females
resumed menses, when they have reached either 90% of
standard body weight for age and height, or were, in
general, 2 kilos above the weight at which they stopped
menstruating [27]. Other predictors for resumption of
menses are body fat percentage, intensity of exercise, or
even IGF1 levels (27–29) but, despite intense nutritional
intervention, a large number of patients remained
amenorrheic, highlighting that stress, anxiety, or
psychological factors may play a role [8,13].
Fertility and fecundity
Fecundity is defined as the biological capacity to
reproduce and is often indirectly assessed in
epidemiological studies by measuring the rate of births, an
index of fertility [30]. Power et al. showed that the fertility
rate of patients with AN (defined as the mean number of
children compared with that of the general population) is
distinctly lower [31]. Moreover, results of a large
longitudinal study describing the long-term outcome of AN
found that only a quarter of anorexic patients became
mothers at the time of follow-up, which is 2 to 3 times less
than that of the general population [32].
Due to their menstrual impairment, females with AN
are generally considered less fertile, and are, indeed, more
likely to seek medical help regarding a fertility problem,
but ultimately only women with both anorexia and bulimia
nervosa are more likely to actually undergo treatment for
infertility [33]. Eating disorders (ED) in general make
individuals prone to infertility due to disruption of the
hypothalamic-pituitary-ovarian axis and subsequent
ovulatory dysfunction [34], but conflicting data exist [35]
and clarifying studies are required.
It is clear that patients with ED are overrepresented in
assisted human reproduction clinics [36] and, in 2014,
Bruneau et al. reported that 8% of females visiting an
infertility clinic met criteria for past AN, a rate higher than
the prevalence in the general population [37]. They have a
lower BMI than infertile patients without a lifetime
diagnosis of AN and a higher level of anxiety [37]. Often
their pathology is not recognized by trained infertility
specialists [38], and even though precise guidelines for ED
management regarding fertility treatment are missing,
current recommendations involve inducing ovulation only
in women with a minimum BMI of 18.5kg/m2 [23].
Nevertheless, it is still questionable to what extent their
poorer fertility is due to ovulatory dysfunction. In the
AVON Longitudinal Study of Parents and Children, 40%
of females with AN admitted that their current pregnancy

was unplanned, probably due to the misbelief that they
were infertile [33]. Hence, it is more likely that anorexic
females lack a stable partner and have ambivalent feelings
towards pregnancy and motherhood, as reported in several
studies [33,37,39], which may explain their lower fertility
rate reported in literature.
Pregnancy and birth outcomes
Pregnant women with lifetime ED are at a higher risk
to develop fetal and maternal complications and have
poorer birth outcomes [40]. However, the evidence is
conflicting, and while some studies note an increased risk
for miscarriages, inadequate maternal weight gain during
pregnancy, cesarean delivery, and small-for-gestationalage babies, or fetal distress [38,41], other studies suggest
that the prognosis for pregnancy and birth for women with
lifetime AN is approximately the same as for healthy
subjects [42]. Watson et al. found an increased rate of
cesarean delivery among patients ever having suffered
from any ED [40], consistent with previous findings of
Pasternak et al. [43]. Moreover, the birthweights tend to
be slightly lower for children born to mothers who had AN
[42-44], but, according to Micalli et al., this difference
seems to be correlated with lower pre-gestational maternal
BMI rather than with the disease itself [44]. Also, while
women with a former diagnosis of AN have a lower, yet,
within normal range BMI, their weight gain during
pregnancy is actually higher than normally expected [41].
Regarding prematurity, AN alone does not predispose to a
higher risk [40] than any other ED or to combined forms of
AN and bulimia [41,43].
Going beyond the clinic
The biological mechanisms underlying the
aforementioned clinical manifestations of AN remain
uncertain. The literature on the role of neurotransmitters
and hormones and their mechanisms of action is still
limited, but recently, scientific evidence has yielded new
insights. In the following sections, we detail some of the
pathophysiological
aspects
relating
reproductive
anomalies to brain function.
Hypothalamic-pituitary-ovarian axis
The physiology of human reproduction in females is
based on three functioning systems: the anterior
hypothalamus where gonadotropin-releasing hormone
(GnRH) is synthesized and secreted from the arcuate
nucleus, the anterior pituitary that responds to GnRH by
secreting follicle stimulating (FSH) and luteinizing
hormone (LH), and the ovaries, that respond to the trophic
action of the so-called gonadotrophins (FSH and LH) by
producing estrogens through the menstrual cycle,
progesterone in the luteal phase, as well as oocytes
necessary for fertilization. The system auto-regulates by
using a feedback mechanism, as estrogens signal at a
3
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central level the availability of peripheral gonadal
hormones and, thus, modulate GnRH secretion [45,46]. In
sexually mature individuals, the release of GnRH follows
a pulsatile pattern, generally every 60 to 90 minutes,
leading to a rhythmic secretion of gonadotrophins [46].
Several studies have demonstrated that acute AN
disrupts the normal functioning of the reproductive axis,
and the pulsatile secretion of LH regresses to a prepubertal
and immature pattern [18], especially when caloric
restriction falls under 30kcal/kg/day [23]. As a result,
GnRH suppression occurs, which then is manifested as
hypothalamic amenorrhea [47]. On the one hand, GnRH
suppression is directly responsible for the changes in LH
amplitude and frequency pulses, which compromise the
secretion of progesterone in thecal cells in the ovary. On
the other hand, it lowers the secretion of FSH which alters
the selection of the dominant follicle and thus diminishes
the synthesis and secretion of estrogens [46]. Therefore,
lower LH, FSH, and estradiol (E2) characterize the
hormonal profile of anorexic patients [48] and positive
correlations exist between the plasmatic level of these
hormones and patient’s BMI [49]. However, surprising
data recently emerged showing that weight-recovered
anorexic patients that were still amenorrheic had higher
levels of sex hormones and gonadotrophins and better
responses to pulsatile GnRH therapy than other women
suffering from hypothalamic amenorrhea [50].
Last, the disproportioned sex distribution of AN
predominating in women raises the hypothesis that,
alongside its contribution to reproductive impairment,
estradiol may also play an etio-pathogenic role, perhaps
affecting satiety control and orexigenic peptides
modulation [18].
Leptin
Leptin is an anorexigenic hormone secreted in adipose
tissue, responsible for centrally signaling satiety and
available energy deposits. It is now widely accepted that
leptin modulates the activity of the reproductive axis by
suppressing it in the case of an inadequate fat reservoir
[51]. It plays a central role in metabolic control of fertility
as it stimulates the hypothalamic expression of GnRH [52],
even though specific leptin receptors in GnRH neurons are
lacking. Compelling evidence suggests that kisspeptin is at
the interplay between leptin and GnRH, and mRNA
encoding leptin receptors have been found in the Kiss1
positive neurons of the arcuate nucleus [53]. Its connection
to the hypothalamic-pituitary-ovarian axis is also shown by
variations of its plasmatic concentrations during the
menstrual cycle, as its level is slightly increased during the
luteal phase and lower during the early follicular phase
[52].
Furthermore, low levels of leptin, suggesting reduced
fat mass, are associated with sexual immaturity [52] as it
4

accompanies low LH secretion [23]. In line with this, in
AN, as in all pathologies involving low fat mass, its level
drops [54,55]. Interestingly and contrary to the general
belief that leptin is a starvation hormone, in one study
leptin was positively associated with appetite, suggesting
that in individuals with AN, body weight regulation may
be altered [55]. Experimental administration of exogenous
leptin prevents stress-induced hyperactivity in anorexic
patients, and even though leptin therapy is a potential
regulator for resumption of menses, its use in AN is not
feasible, as it decreases both appetite and adipose tissue
[18].
Kisspeptin
Initially described two decades ago as a metastaticsuppressor factor of melanoma cells [56], after the
identification of its receptor, kiss1R, kisspeptin was
defined as a neuropeptide and assigned several endocrine
and metabolic functions [57]. It is expressed in a variety of
peripheral tissues within the gonads, placenta, small
intestine, and pancreas, but its main site of action is located
in the brain, specifically within hypothalamic neurons
located in the arcuate nucleus (ARC) and the preoptic area,
which corresponds to the rostral periventricular region of
the third ventricle (RP3V) in rodents [45]. It plays a major
role in reproduction as it facilitates the feedback
mechanisms of the hypothalamic-pituitary-ovarian axis
and triggers puberty initiation [58]. GnRH neurons lack
requisite receptors for estradiol, but seem to have an
affinity for kisspeptin, which mediates the dual feedback
of the sexual hormones: negative feedback through ARC
which is necessary for GnRH pulse generation, and
positive feedback through RP3V which is necessary for LH
pre-ovulatory surge [45]. Moreover, Millar et al. found that
while kisspeptin may not be important in maintaining basal
LH levels, it is, nevertheless, crucial for its pre-ovulatory
stimulation [59].
Other than its role in reproductive function, kisspeptin
also seems involved in inducing adequate reproductive
behavior, as observed in animal studies [60], as well as
modulating reactions to fear [61] and anxiety [62]. Outside
the brain, among its increasingly identified roles,
kisspeptin is involved in the implantation of the embryo, in
the decidualisation of the endometrium and, by binding to
its placental receptors, in the angiogenesis of the placenta
[63]. As a further matter, by exploring its actions on
metabolism, Tolson et al. showed that kisspeptin is
involved in maintaining glucose homeostasis and weight
[64].
The scientific evidence of kisspeptin variation in
anorexia cases is yet sparse. However, given that food
deprivation suppresses hypothalamic kiss1 mRNA [65],
and that experimental administration of kisspeptin in
women with functional hypothalamic amenorrhea
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increased LH pulses [46], this neuropeptide may serve
important functions. The few data available have shown a
negative correlation between kisspeptin and intensity of
exercise [66,67], but have failed to establish a connection
with anxiety in AN patients [67]. An interesting finding
reported by Bacopoulou is that menstruating females with
atypical AN have higher levels of kisspeptin when
compared to amenorrheic anorexic patients [49],
suggesting that kisspeptin rises in order to keep a normal
gonadal function.
Others
Many other neurotransmitters participate in the
dynamics of reproductive regulation. To name a few,
ghrelin, which is synthetized in the digestive system, is one
of the most potent orexigenic hormones. It inhibits GnRH
secretion and its concentration is diminished in AN patients
[47]. Vasopressin, alongside its role in water reabsorption,
is also involved in social behavior and sexual motivation
[18], and even though its variation in anorexia is yet
debatable, it also seems to stimulate adrenocorticotropic
hormone (ACTH), which blunts functioning of the
reproductive axis [66]. Last, there is controversy regarding
the effects of oxytocin on anxiety, and while some authors
report low levels in AN, interfering with empathy and
attachment mechanisms, others consider it a potent
anxiogenic factor that limits food intake of anorexic
females [18,66].

Highlights
✓ Anorexia nervosa leads to functional amenorrhea and
impaired reproductive function.
✓ Females with a lifetime diagnosis of anorexia nervosa
are more likely to seek specialized medical help at
infertility clinics.
✓ Pregnancy and birth outcomes of ever-affected women
is controversial, but in the long term is rather good and
similar to that within the general population.

Conclusions
Women with current AN have an impaired fertility
status, but those who have recovered generally have, if
desired and on a long term, a high chance for pregnancy
and a good birth outcome. There are clear relationships
between reproductive function and adipose tissue,
nutritional status, intensity of physical exercises, and
mental state. Although some of the underlying mechanisms
for AN and reproductive anomalies are now being
clarified, many hypotheses remain unexplored. To date,
clinical trials regarding the dynamics of neurotransmitter
involvement in the reproductive function of AN women is
sparse, but a rising interest in the field will likely shed more
light on the issue.
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